Reviewer Packet
Private review guide
This page is the reviewer guide for the private Dravenkor site. It tells trusted reviewers what to look at, what kind of feedback is useful, and what decisions their feedback should inform.
The goal is not to explain every internal plan. The goal is to help reviewers answer one practical question:
Is the Dravenkor / ODIN / DORI story clear, credible, and worth advancing into the next product proof?
What reviewers are evaluating
| Review area | What we need to learn |
|---|---|
| Problem clarity | Do reviewers understand the operational gap Dravenkor is trying to solve? |
| Category clarity | Does Technology Health feel understandable, useful, and differentiated? |
| Product shape | Do ODIN, DORI, Mimir, and Yggdrasil fit together without too much explanation? |
| First proof loop | Does map → evidence → observability → advisory → recommendation feel like a useful first workflow? |
| Trust boundary | Does the local-first, evidence-backed, non-mutating posture feel safe and credible? |
| Commercial direction | Does the business path feel plausible without needing detailed pricing or forecasts? |
| Next proof | What would reviewers need to see next before believing the direction is real? |
What not to review yet
Reviewers should not treat this as a finished public site, final product demo, or complete commercial model.
Avoid spending review time on:
- final visual polish;
- exact pricing;
- implementation framework details;
- exhaustive product scope;
- production deployment details;
- investor-grade financial forecasts.
Those matter later. For this review, clarity and credibility matter first.
Suggested reviewer intro
Use this as the opening note when sharing the private-site draft.
I’m looking for targeted feedback on a private Dravenkor review site.
Dravenkor is exploring Technology Health: a way for small teams, home-lab operators, consultants, and growing businesses to better understand what they run, what matters, and what to improve next.
ODIN is the operational cockpit. DORI is the guided recommendation experience. Mimir is the local-first foundation behind the evidence and context. Yggdrasil is the community validation path.
This is not a public launch site or finished product demo. The main question is whether the story, first proof loop, product framing, and commercial direction are clear and credible enough to continue.
The most useful feedback is simple: what is clear, what is confusing, what feels credible, what feels overclaimed, and what proof you would need next.
Recommended reading path
| Step | Page | Time | What to evaluate |
|---|---|---|---|
| 1 | Home | 2 min | Is the promise clear at a glance? |
| 2 | Challenge | 3 min | Does the problem feel real and specific? |
| 3 | About Dravenkor | 3 min | Does the founder story make the mission feel credible? |
| 4 | Technology Health | 4 min | Is the category understandable? |
| 5 | ODIN + DORI | 5 min | Is the platform/guide relationship clear? |
| 6 | Proof Loop | 5 min | Does the first workflow feel useful and safe? |
| 7 | Product Path + Yggdrasil | 5 min | Does community validation before scale make sense? |
| 8 | Commercial Path | 4 min | Does the business direction feel plausible at a high level? |
| 9 | Roadmap & Ask | 3 min | Are the next steps and ask clear? |
Recommended total review time: 30-35 minutes.
For a shorter review, use:
- Home;
- Challenge;
- ODIN + DORI;
- Proof Loop;
- Roadmap & Ask.
10-minute live walkthrough
Use this for a short advisor or investor call.
| Time | Topic | Talk track | What to listen for |
|---|---|---|---|
| 0:00-1:00 | Frame | “This is a private review draft, not a launch site.” | Do they understand the stage? |
| 1:00-2:00 | Problem | “Operators have tools, but still lack shared context and confidence.” | Does the pain sound familiar? |
| 2:00-3:00 | Technology Health | “The category is about knowing what exists, what matters, and what to improve next.” | Does the category land? |
| 3:00-4:30 | ODIN | “ODIN organizes assets, relationships, evidence, readiness, and recommendations.” | Is ODIN’s role clear? |
| 4:30-5:30 | DORI | “DORI explains what matters and turns evidence into next-step guidance.” | Does DORI avoid sounding like a generic chatbot? |
| 5:30-7:30 | Proof Loop | “A user maps a service, attaches evidence, sees risk/coverage signals, and gets a safe recommendation.” | Does the workflow feel useful? |
| 7:30-8:30 | Trust boundary | “Community observes and advises. It does not mutate systems.” | Does the safety posture feel credible? |
| 8:30-9:15 | Commercial path | “Commercialization follows validation: community proof, subscriptions, reviews, and services.” | Does the path feel plausible? |
| 9:15-10:00 | Ask | “What is clear, confusing, overclaimed, or missing?” | Do they give actionable feedback? |
20-minute deeper walkthrough
Use this when a reviewer has product, technical, or investor depth.
| Time | Topic | Additions |
|---|---|---|
| 0:00-2:00 | Context | Explain that this is a private review artifact for story, product framing, and proof-loop validation. |
| 2:00-5:00 | Challenge | Walk through the practical questions operators face: what exists, what is exposed, what is backed up, what is monitored, what should improve first. |
| 5:00-7:00 | Technology Health | Explain the category as operational confidence, not another monitoring dashboard. |
| 7:00-9:30 | ODIN | Explain cockpit surfaces: asset context, relationships, evidence, readiness, observability, recommendations. |
| 9:30-11:00 | DORI | Explain guided recommendations and downloadable deliverables. Keep the AI claim modest. |
| 11:00-14:00 | Proof Loop | Walk through the first safe workflow and ask whether it feels valuable. |
| 14:00-16:00 | Mimir Foundation | Explain the local-first foundation at a high level only. Avoid internal service detail unless asked. |
| 16:00-18:00 | Product Path + Yggdrasil | Explain community validation, then Plus/Pro/Managed as possible maturity paths. |
| 18:00-19:00 | Commercial Path | Keep this high level: business direction, not forecasts. |
| 19:00-20:00 | Feedback ask | Ask for the strongest objection and the next proof they would need. |
Reviewer questions
Advisor questions
| Area | Question |
|---|---|
| Clarity | Where does the story become unclear, too abstract, or too technical? |
| Category | Does Technology Health feel like a useful category? |
| Trust | Does the local-first and non-mutating posture feel credible? |
| Audience | Who do you think this is most clearly for first? |
| Missing proof | What would make the direction easier to believe? |
Technical reviewer questions
| Area | Question |
|---|---|
| Product boundary | Is ODIN clearly different from a dashboard, CMDB, monitoring stack, or ticket system? |
| DORI boundary | Is DORI useful as guidance rather than “just a chatbot”? |
| Proof loop | Does map → evidence → observability → advisory → recommendation make technical sense? |
| Evidence | Are confidence, provenance, and missing-evidence ideas clear enough? |
| Risk | What claim feels under-supported? |
Investor questions
| Area | Question |
|---|---|
| Wedge | Is community/home-lab validation a credible first wedge? |
| Market | Which early audience feels most plausible: home lab, consultant, SMB, or managed-service partner? |
| Commercial path | Does validation → subscription → review/advisory → managed support feel plausible? |
| Proof needed | What proof point would make this worth a deeper investor/advisor conversation? |
| Risk | What is the biggest risk: market education, differentiation, support burden, execution capacity, or trust? |
Early user / community reviewer questions
| Area | Question |
|---|---|
| Usefulness | Would a safe environment map and readiness/advisory cards help you? |
| Trust | Would you try a tool that starts by observing and advising without changing systems? |
| DORI | Would structured recommendations and downloadable reports be useful even without chat? |
| Onboarding | What source would you want to connect or import first? |
| Friction | What would stop you from trying the Community path? |
Feedback capture model
Use this structure when reviewing call notes or async comments.
| Field | Meaning | Example |
|---|---|---|
| Reviewer | person / role | advisor, investor, technical reviewer |
| Page or section | where the feedback applies | Proof Loop |
| Type | clarity, risk, opportunity, objection, missing proof, copy edit | missing proof |
| Comment | raw feedback | “I need to see how evidence confidence is shown.” |
| Priority | low, medium, high | medium |
| Action | revise copy, create follow-up, defer, reject | revise copy |
| Owner | who resolves | Chris / Tars / Ravenforge |
| Status | open, in progress, resolved, deferred | open |
Useful feedback buckets:
| Bucket | Use |
|---|---|
copy:clarity |
wording or story is unclear |
product:positioning |
product/category framing issue |
proof:missing |
reviewer needs evidence, screenshots, or demo artifact |
risk:trust |
concern around privacy, AI, automation, governance, or safety |
commercial:model |
business path, market, pricing, conversion, or support concern |
visual:needed |
concept needs a diagram, card, or mockup to land |
implementation:later |
valid point, but not needed before the next proof step |
Decision gates before the next proof step
Use these gates to decide whether the private-site story is ready to support the next build/demo effort.
| Gate | Required answer | Pass signal |
|---|---|---|
| Narrative clarity | Can reviewers describe Dravenkor, Technology Health, ODIN, DORI, and the Proof Loop in their own words? | mostly yes |
| Proof-loop credibility | Does the first workflow feel useful and not overclaimed? | mostly yes |
| Trust boundary | Are local-first, evidence-backed, non-mutating claims clear? | mostly yes |
| Commercial containment | Is the high-level commercial direction enough for now? | yes |
| Reviewer objections | Are major objections captured and either resolved or intentionally deferred? | yes |
| Visual support | Are the key visuals good enough to explain the idea? | yes |
| Next proof | Is it clear what proof/demo should come next? | yes |
If these gates pass, the next step is to tighten the proof/demo plan and use reviewer feedback to prioritize what must be shown first.
If they do not pass, revise the narrative, visuals, or proof-loop framing before building more machinery.
Recommended message template
Subject:
Private review request: Dravenkor / ODIN Technology Health site draft
Message:
I’m looking for targeted feedback on an early private-site draft for Dravenkor and ODIN, a Technology Health platform concept.
This is not a public launch site or a finished demo. The goal is to validate whether the story, first proof loop, product framing, and commercial direction are clear enough to justify the next proof step.
Most useful feedback:
- What is clear?
- What is confusing?
- What feels credible?
- What feels overclaimed?
- What proof would you need next?
Suggested review time: 30 minutes.
Review recommendation
Use this page as the guide for the first private review cycle.
After the review cycle, group feedback into three decisions:
- what copy or visual language should change now;
- what proof/demo artifact should be built next;
- what objections are real but can safely wait.
Then update the site before sharing it more broadly. Nothing says “strategic clarity” like not making every reviewer rediscover the same pothole.
Reviewer questions
- Does this packet help reviewers give useful feedback quickly?